4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000950170-24-019432
Options or other derivatives
- CHIEF FINANCIAL OFFICER acquired 115,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| King Michael CHIEF FINANCIAL OFFICER | 2024-02-21 | Grant or award · Employee Stock Option (right to buy) | +115,000 | 115,000 | D | ||
Loading xslF345X05/ownership.xml…